Celecoxib-Mepha 100 mg
Celecoxib-Mepha 100 mg is a medicine authorised by Swissmedic under authorisation number 63126. The authorisation holder is Mepha Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 21 June 2013 and the authorisation is valid without a time limit. ATC code M01AH01 places the medicine in the group Anti-inflammatory and antirheumatic products.
| Authorisation number | 63126 |
|---|---|
| Name | Celecoxib-Mepha 100 mg |
| Full name | Celecoxib-Mepha 100 mg, Kapseln |
| Authorisation holder | Mepha Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | M01AH01 |
| First authorisation | 21 June 2013 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Celecoxib-Mepha 100 mg, Kapseln | B | 21 June 2013 |
| 2 | Celecoxib-Mepha 200 mg, Kapseln | B | 21 June 2013 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Kapsel(n) | M01AH01 | 07.10.1. | B |
| 3 | 30 | Kapsel(n) | M01AH01 | 07.10.1. | B |
| 5 | 100 | Kapsel(n) | M01AH01 | 07.10.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Celecoxib-Mepha 100 mg authorised in Switzerland?
Yes. Celecoxib-Mepha 100 mg is authorised by Swissmedic under authorisation number 63126, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Celecoxib-Mepha 100 mg have?
Celecoxib-Mepha 100 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Celecoxib-Mepha 100 mg?
The authorisation holder is Mepha Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.